Japanese Version of the Mobile App Rating Scale (MARS): Development and Validation

被引:10
|
作者
Yamamoto, Kazumichi [1 ,2 ,3 ]
Ito, Masami [1 ,2 ]
Sakata, Masatsugu [1 ,2 ]
Koizumi, Shiho [4 ]
Hashisako, Mizuho [5 ]
Sato, Masaaki [6 ]
Stoyanov, Stoyan R. [7 ]
Furukawa, Toshi A. [1 ,2 ]
Yamamoto, Kazumichi [1 ,2 ,3 ]
机构
[1] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Hlth Promot, Kyoto, Japan
[2] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Human Behav, Kyoto, Japan
[3] Inst Airway Dis, Res Unit, Takarazuka, Hyogo, Japan
[4] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Hlth Informat, Kyoto, Japan
[5] Rikkyo Univ, Dept Sociol, Tokyo, Japan
[6] Univ Tokyo Hosp, Organ Transplantat Ctr, Tokyo, Japan
[7] Queensland Univ Technol, Sch Psychol & Counselling, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia
来源
JMIR MHEALTH AND UHEALTH | 2022年 / 10卷 / 04期
关键词
mobile health apps; MHAs; mHealth; mobile application; mobile application rating scale; MARS; scale development; mental health; mobile health applications; TRANSLATION; INSTRUMENTS; ADAPTATION;
D O I
10.2196/33725
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The number of mobile health (mHealth) apps continues to rise each year. Widespread use of the Mobile App Rating Scale (MARS) has allowed objective and multidimensional evaluation of the quality of these apps. However, no Japanese version of MARS has been made available to date. Objective: The purposes of this study were (1) to develop a Japanese version of MARS and (2) to assess the translated version's reliability and validity in evaluating mHealth apps. Methods: To develop the Japanese version of MARS, cross-cultural adaptation was used using a universalist approach. A total of 50 mental health apps were evaluated by 2 independent raters. Internal consistency and interrater reliability were then calculated. Convergent and divergent validity were assessed using multitrait scaling analysis and concurrent validity. Results: After cross-cultural adaptation, all 23 items from the original MARS were included in the Japanese version. Following translation, back-translation, and review by the author of the original MARS, a Japanese version of MARS was finalized Internal consistency was acceptable by all subscales of objective and subjective quality (Cronbach alpha=.78-.89). Interrater reliability was deemed acceptable, with the intraclass correlation coefficient (ICC) ranging from 0.61 to 0.79 for all subscales, except for "functionality," which had an ICC of 0.40. Cmwergent/divergent validity and concurrent validity were also considered acceptable. The rate of missing responses was high in several items in the "information" subscale. Conclusions: A Japanese version of MARS was developed and shown to be reliable and valid to a degree that was comparable to the original MARS. This Japanese version of MARS can be used as a standard to evaluate the quality and credibility of mHealth apps.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] The German Version of the Mobile App Rating Scale (MARS-G): Development and Validation Study
    Messner, Eva-Maria
    Terhorst, Yannik
    Barke, Antonia
    Baumeister, Harald
    Stoyanov, Stoyan
    Hides, Leanne
    Kavanagh, David
    Pryss, Ruediger
    Sander, Lasse
    Probst, Thomas
    JMIR MHEALTH AND UHEALTH, 2020, 8 (03):
  • [2] Development and validation of the Turkish version of the Mobile App Rating Scale - MARS-TR
    Mendi, Onur
    Sari, Merve Kiymac
    Stoyanov, Stoyan
    Mendi, Basak
    INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 2022, 166
  • [3] The Arabic Version of the Mobile App Rating Scale: Development and Validation Study
    Bardus, Marco
    Awada, Nathalie
    Ghandour, Lilian A.
    Fares, Elie-Jacques
    Gherbal, Tarek
    Al-Zanati, Tasnim
    Stoyanov, Stoyan R.
    JMIR MHEALTH AND UHEALTH, 2020, 8 (03):
  • [4] Development and Validation of the User Version of the Mobile Application Rating Scale (uMARS)
    Stoyanov, Stoyan R.
    Hides, Leanne
    Kavanagh, David J.
    Wilson, Hollie
    JMIR MHEALTH AND UHEALTH, 2016, 4 (02): : 589 - 593
  • [5] The Persian Version of the Mobile Application Rating Scale (MARS-Fa): Translation and Validation Study
    Barzegari, Saeed
    Kia, Ali Sharifi
    Bardus, Marco
    Stoyanov, Stoyan R.
    GhaziSaeedi, Marjan
    Rafizadeh, Mouna
    JMIR FORMATIVE RESEARCH, 2022, 6 (12)
  • [6] Validation of the Mobile Application Rating Scale (MARS)
    Terhorst, Yannik
    Philippi, Paula
    Sander, Lasse B.
    Schultchen, Dana
    Paganini, Sarah
    Bardus, Marco
    Santo, Karla
    Knitza, Johannes
    Machado, Gustavo C.
    Schoeppe, Stephanie
    Bauereiss, Natalie
    Portenhauser, Alexandra
    Domhardt, Matthias
    Walter, Benjamin
    Krusche, Martin
    Baumeister, Harald
    Messner, Eva-Maria
    PLOS ONE, 2020, 15 (11):
  • [7] Promoting Health via mHealth Applications Using a French Version of the Mobile App Rating Scale: Adaptation and Validation Study
    Saliasi, Ina
    Martinon, Prescilla
    Darlington, Emily
    Smentek, Colette
    Tardivo, Delphine
    Bourgeois, Denis
    Dussart, Claude
    Carrouel, Florence
    Fraticelli, Laurie
    JMIR MHEALTH AND UHEALTH, 2021, 9 (08):
  • [8] Turkish Validation of the User Version of the Mobile Application Rating Scale
    Calik, Gokhan
    Kartal, Betul Bersan
    Stoyanov, Stoyan
    Gravas, Stavros
    Othman, Lavin
    de la Rosette, Jean
    Albayrak, Selami
    Laguna, Pilar
    TURKISH JOURNAL OF UROLOGY, 2022, 48 (03): : 236 - 242
  • [9] French Version of the User Mobile Application Rating Scale: Adaptation and Validation Study
    Saliasi, Ina
    Lan, Romain
    Rhanoui, Maryem
    Fraticelli, Laurie
    Viennot, Stephane
    Tardivo, Delphine
    Clement, Celine
    de Vigneulles, Benjamin du Sartz
    Bernard, Sandie
    Darlington-Bernard, Adeline
    Dussart, Claude
    Bourgeois, Denis
    Carrouel, Florence
    JMIR MHEALTH AND UHEALTH, 2024, 12
  • [10] Mobile Applications for Hemodialysis: Evaluation Using the Mobile App Rating Scale (MARS)
    Esmaeeli, Erfan
    Khorashadizadeh, Mohadeseh Sadat
    Rahmani, Meysam
    SEMINARS IN DIALYSIS, 2025, 38 (02) : 102 - 110